China Food and Drug Administration, Decision on Revising Matters Relevant to the Administration of the Registration of Imported Pharmaceuticals (Draft for Comments)
May 9, 2017
Issued: March 17 2017
Main contents: With a view to encouraging the simultaneous conduct of foreign and domestic clinical trials, after approval,…
This premium content is reserved for
China Law & Practice Subscribers.
- Unlimited access to Chinalawandpractice.com site and digital newsletters
- 5 free articles across the ALM subscription network every 30 days
- Exclusive discounts on ALM events and publications
Continue reading by getting
started with a subscription.